Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.11600359 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.11600359 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.90041249 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.39707424 |
5 | NIK/NF-kappaB signaling (GO:0038061) | 4.87779695 |
6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.65517703 |
7 | detection of other organism (GO:0098543) | 4.64868492 |
8 | detection of bacterium (GO:0016045) | 4.64122770 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12329972 |
10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.09757240 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05976514 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87782773 |
13 | negative regulation of cell killing (GO:0031342) | 3.87782773 |
14 | detection of external biotic stimulus (GO:0098581) | 3.84177103 |
15 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.77965396 |
16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68959961 |
17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68959961 |
18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68959961 |
19 | modulation by symbiont of host immune response (GO:0052553) | 3.68959961 |
20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68959961 |
21 | modulation by symbiont of host defense response (GO:0052031) | 3.68959961 |
22 | T cell migration (GO:0072678) | 3.62923397 |
23 | positive regulation of interferon-alpha production (GO:0032727) | 3.61491030 |
24 | positive regulation of B cell differentiation (GO:0045579) | 3.61203442 |
25 | negative thymic T cell selection (GO:0045060) | 3.60379574 |
26 | response to muramyl dipeptide (GO:0032495) | 3.60087157 |
27 | positive thymic T cell selection (GO:0045059) | 3.59758135 |
28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58481917 |
29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48500994 |
30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48373222 |
31 | negative T cell selection (GO:0043383) | 3.45945511 |
32 | regulation of interferon-alpha production (GO:0032647) | 3.45730890 |
33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.43837002 |
34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.43510566 |
35 | immunoglobulin mediated immune response (GO:0016064) | 3.42118945 |
36 | detection of biotic stimulus (GO:0009595) | 3.37136072 |
37 | detection of molecule of bacterial origin (GO:0032490) | 3.31928878 |
38 | regulation of mast cell degranulation (GO:0043304) | 3.30598654 |
39 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.28099531 |
40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.26550406 |
41 | regulation of B cell differentiation (GO:0045577) | 3.25334625 |
42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23282793 |
43 | response to host (GO:0075136) | 3.23282793 |
44 | response to host defenses (GO:0052200) | 3.23282793 |
45 | neutrophil activation involved in immune response (GO:0002283) | 3.21454216 |
46 | * response to type I interferon (GO:0034340) | 3.20961000 |
47 | natural killer cell mediated immunity (GO:0002228) | 3.20559482 |
48 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.20559482 |
49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19643627 |
50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16403823 |
51 | * type I interferon signaling pathway (GO:0060337) | 3.16174130 |
52 | * cellular response to type I interferon (GO:0071357) | 3.16174130 |
53 | regulation of leukocyte degranulation (GO:0043300) | 3.13936762 |
54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12734125 |
55 | thymic T cell selection (GO:0045061) | 3.11893833 |
56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11078065 |
57 | macrophage activation involved in immune response (GO:0002281) | 3.09659301 |
58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09233036 |
59 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.05580695 |
60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04153306 |
61 | negative regulation of interleukin-12 production (GO:0032695) | 3.03708348 |
62 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.03469389 |
63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01102662 |
64 | myeloid dendritic cell differentiation (GO:0043011) | 3.00973327 |
65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98339082 |
66 | leukocyte aggregation (GO:0070486) | 2.96219833 |
67 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95653842 |
68 | neutrophil activation (GO:0042119) | 2.95222857 |
69 | response to peptidoglycan (GO:0032494) | 2.95152136 |
70 | positive regulation of humoral immune response (GO:0002922) | 2.93434723 |
71 | myeloid dendritic cell activation (GO:0001773) | 2.93327353 |
72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93213855 |
73 | regulation of antigen processing and presentation (GO:0002577) | 2.89897353 |
74 | B cell receptor signaling pathway (GO:0050853) | 2.89337619 |
75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.89027259 |
76 | granulocyte activation (GO:0036230) | 2.88883159 |
77 | positive regulation of interferon-beta production (GO:0032728) | 2.88483949 |
78 | T cell selection (GO:0045058) | 2.86328013 |
79 | macrophage activation (GO:0042116) | 2.86148244 |
80 | regulation of response to interferon-gamma (GO:0060330) | 2.85609006 |
81 | response to protozoan (GO:0001562) | 2.84324928 |
82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83143852 |
83 | negative regulation of phagocytosis (GO:0050765) | 2.81218938 |
84 | tolerance induction (GO:0002507) | 2.79667146 |
85 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78078934 |
86 | microglial cell activation (GO:0001774) | 2.76956860 |
87 | natural killer cell differentiation (GO:0001779) | 2.75944104 |
88 | regulation of RIG-I signaling pathway (GO:0039535) | 2.75321757 |
89 | regulation of tolerance induction (GO:0002643) | 2.74011979 |
90 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73941996 |
91 | cellular response to zinc ion (GO:0071294) | 2.72031946 |
92 | respiratory burst (GO:0045730) | 2.71555257 |
93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71502582 |
94 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.70757837 |
95 | B cell homeostasis (GO:0001782) | 2.70522610 |
96 | cellular response to interleukin-15 (GO:0071350) | 2.69876137 |
97 | response to interleukin-15 (GO:0070672) | 2.69820462 |
98 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69033024 |
99 | B cell mediated immunity (GO:0019724) | 2.68481517 |
100 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67727498 |
101 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.66531565 |
102 | leukocyte cell-cell adhesion (GO:0007159) | 2.66531056 |
103 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.66483220 |
104 | regulation of hypersensitivity (GO:0002883) | 2.65389519 |
105 | growth hormone receptor signaling pathway (GO:0060396) | 2.64420229 |
106 | regulation of T cell tolerance induction (GO:0002664) | 2.63958587 |
107 | negative regulation of interleukin-6 production (GO:0032715) | 2.63854254 |
108 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.62968102 |
109 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62435925 |
110 | T-helper 1 type immune response (GO:0042088) | 2.62238640 |
111 | germinal center formation (GO:0002467) | 2.62106401 |
112 | mature B cell differentiation (GO:0002335) | 2.61463776 |
113 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60795815 |
114 | positive regulation of interleukin-2 production (GO:0032743) | 2.59561568 |
115 | regulation of mast cell activation (GO:0033003) | 2.58903479 |
116 | dendritic cell differentiation (GO:0097028) | 2.58723278 |
117 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.53511301 |
118 | cellular extravasation (GO:0045123) | 2.53178840 |
119 | positive T cell selection (GO:0043368) | 2.51991539 |
120 | regulation of cholesterol storage (GO:0010885) | 2.50330341 |
121 | defense response to protozoan (GO:0042832) | 2.47950132 |
122 | negative regulation of innate immune response (GO:0045824) | 2.47905257 |
123 | regulation of interleukin-12 production (GO:0032655) | 2.47256334 |
124 | myeloid cell activation involved in immune response (GO:0002275) | 2.46879131 |
125 | leukocyte mediated cytotoxicity (GO:0001909) | 2.46509439 |
126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45789990 |
127 | pinocytosis (GO:0006907) | 2.45549935 |
128 | mannose metabolic process (GO:0006013) | 2.44657245 |
129 | cytokine secretion (GO:0050663) | 2.44529232 |
130 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.42987482 |
131 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.39971243 |
132 | response to host immune response (GO:0052572) | 2.39971243 |
133 | regulation of interferon-beta production (GO:0032648) | 2.39045092 |
134 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.38875189 |
135 | regulation of necroptotic process (GO:0060544) | 2.38443185 |
136 | positive regulation of interleukin-12 production (GO:0032735) | 2.37901070 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.90980259 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82636284 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16331824 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14126695 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.10478218 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05985792 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96867674 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.89372311 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86113833 |
10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80554135 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.75957051 |
12 | MYC_22102868_ChIP-Seq_BL_Human | 2.74252415 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69073828 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61438929 |
15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.49448838 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45115378 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37002932 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 2.24070645 |
19 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20770586 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.20111305 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14367983 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12805722 |
23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10713700 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09774838 |
25 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09227426 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 2.04202095 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00905664 |
28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00531498 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 1.95774929 |
30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95089701 |
31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94034459 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91229804 |
33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.86540549 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83081175 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.81270438 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80863755 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79100562 |
38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78863868 |
39 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77319147 |
40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.75717025 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74193041 |
42 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71677417 |
43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.62913495 |
44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61473944 |
45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60593476 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60102320 |
47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56839141 |
48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56154555 |
49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52672736 |
50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51141155 |
51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49003052 |
52 | MAF_26560356_Chip-Seq_TH2_Human | 1.46345817 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42298070 |
54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39852108 |
55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38966583 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38441895 |
57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35694811 |
58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32111113 |
59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30574329 |
60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30016493 |
61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29872420 |
62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29776070 |
63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28751539 |
64 | P68_20966046_ChIP-Seq_HELA_Human | 1.28427190 |
65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28110412 |
66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26609564 |
67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26462258 |
68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26201205 |
69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25559031 |
70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25292245 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24008354 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23484644 |
73 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22797003 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22597848 |
75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22539356 |
76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21932074 |
77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20227974 |
78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19711943 |
79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17156213 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15094457 |
81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12028453 |
82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09839900 |
83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08864530 |
84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06420430 |
85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05626612 |
86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05053635 |
87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04248609 |
88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04186281 |
89 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03328021 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02256272 |
91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01085241 |
92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00832605 |
93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99880732 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99840435 |
95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99608761 |
96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98503722 |
97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98191955 |
98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97121571 |
99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95984411 |
100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95556755 |
101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94552098 |
102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93148179 |
103 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92912024 |
104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92802853 |
105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92743631 |
106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91759625 |
107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90255131 |
108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.89863392 |
109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89338637 |
110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88979963 |
111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88810274 |
112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88148922 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86860246 |
114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86787245 |
115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86307927 |
116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84700539 |
117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84621150 |
118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83214353 |
119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82955708 |
120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80555501 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.76755440 |
2 | MP0000685_abnormal_immune_system | 3.18635504 |
3 | MP0001790_abnormal_immune_system | 2.85103184 |
4 | MP0005387_immune_system_phenotype | 2.85103184 |
5 | MP0003303_peritoneal_inflammation | 2.78897666 |
6 | * MP0001800_abnormal_humoral_immune | 2.70004618 |
7 | * MP0003436_decreased_susceptibility_to | 2.67995182 |
8 | MP0009785_altered_susceptibility_to | 2.53942726 |
9 | MP0005671_abnormal_response_to | 2.48877043 |
10 | * MP0005000_abnormal_immune_tolerance | 2.42804302 |
11 | * MP0002452_abnormal_antigen_presenting | 2.40236720 |
12 | * MP0005025_abnormal_response_to | 2.33156043 |
13 | MP0009840_abnormal_foam_cell | 2.31821221 |
14 | * MP0002723_abnormal_immune_serum | 2.30758679 |
15 | MP0002419_abnormal_innate_immunity | 2.29825156 |
16 | MP0002166_altered_tumor_susceptibility | 2.24239670 |
17 | MP0004510_myositis | 2.18134919 |
18 | * MP0001819_abnormal_immune_cell | 2.16402729 |
19 | * MP0002420_abnormal_adaptive_immunity | 2.15685692 |
20 | MP0006082_CNS_inflammation | 2.11487917 |
21 | MP0008260_abnormal_autophagy | 2.10699889 |
22 | MP0003300_gastrointestinal_ulcer | 2.08789270 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.06608691 |
24 | MP0005058_abnormal_lysosome_morphology | 1.95962140 |
25 | MP0004947_skin_inflammation | 1.95615800 |
26 | MP0003763_abnormal_thymus_physiology | 1.93623259 |
27 | * MP0002398_abnormal_bone_marrow | 1.93533534 |
28 | MP0005464_abnormal_platelet_physiology | 1.92083933 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.87078442 |
30 | MP0002405_respiratory_system_inflammati | 1.86490480 |
31 | * MP0000716_abnormal_immune_system | 1.82133829 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.82000298 |
33 | MP0001873_stomach_inflammation | 1.81219583 |
34 | MP0002006_tumorigenesis | 1.75119054 |
35 | MP0010155_abnormal_intestine_physiology | 1.73034934 |
36 | MP0000689_abnormal_spleen_morphology | 1.66655425 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.66155748 |
38 | MP0001845_abnormal_inflammatory_respons | 1.64989696 |
39 | MP0002254_reproductive_system_inflammat | 1.64520389 |
40 | MP0003172_abnormal_lysosome_physiology | 1.60106029 |
41 | MP0002722_abnormal_immune_system | 1.59740033 |
42 | MP0003724_increased_susceptibility_to | 1.58797873 |
43 | MP0001853_heart_inflammation | 1.57549466 |
44 | MP0002396_abnormal_hematopoietic_system | 1.56979267 |
45 | * MP0002429_abnormal_blood_cell | 1.54653054 |
46 | MP0010352_gastrointestinal_tract_polyps | 1.54498316 |
47 | MP0009278_abnormal_bone_marrow | 1.52498079 |
48 | MP0002132_abnormal_respiratory_system | 1.51964312 |
49 | * MP0008469_abnormal_protein_level | 1.46744506 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.43022660 |
51 | MP0001545_abnormal_hematopoietic_system | 1.43022660 |
52 | MP0003705_abnormal_hypodermis_morpholog | 1.41593182 |
53 | MP0003828_pulmonary_edema | 1.40921783 |
54 | MP0005310_abnormal_salivary_gland | 1.39725743 |
55 | MP0000569_abnormal_digit_pigmentation | 1.37859878 |
56 | MP0004381_abnormal_hair_follicle | 1.36906247 |
57 | MP0005076_abnormal_cell_differentiation | 1.35415641 |
58 | MP0003448_altered_tumor_morphology | 1.33449593 |
59 | MP0010307_abnormal_tumor_latency | 1.32439974 |
60 | MP0005360_urolithiasis | 1.31543371 |
61 | * MP0001533_abnormal_skeleton_physiology | 1.27650491 |
62 | MP0004808_abnormal_hematopoietic_stem | 1.23770451 |
63 | MP0003183_abnormal_peptide_metabolism | 1.22106749 |
64 | MP0000703_abnormal_thymus_morphology | 1.21830689 |
65 | MP0003566_abnormal_cell_adhesion | 1.19982009 |
66 | MP0000609_abnormal_liver_physiology | 1.19946410 |
67 | MP0000604_amyloidosis | 1.12919292 |
68 | MP0000858_altered_metastatic_potential | 1.12792531 |
69 | MP0003866_abnormal_defecation | 1.10673381 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.08881502 |
71 | MP0002139_abnormal_hepatobiliary_system | 1.05739963 |
72 | MP0009764_decreased_sensitivity_to | 1.03511386 |
73 | MP0003453_abnormal_keratinocyte_physiol | 1.02797031 |
74 | MP0005365_abnormal_bile_salt | 1.00098578 |
75 | MP0009763_increased_sensitivity_to | 0.99328574 |
76 | MP0004883_abnormal_blood_vessel | 0.98899375 |
77 | MP0005083_abnormal_biliary_tract | 0.95230457 |
78 | MP0002933_joint_inflammation | 0.95146805 |
79 | MP0003690_abnormal_glial_cell | 0.94581542 |
80 | MP0000490_abnormal_crypts_of | 0.94455264 |
81 | MP0005023_abnormal_wound_healing | 0.90539864 |
82 | MP0001849_ear_inflammation | 0.87653647 |
83 | MP0001348_abnormal_lacrimal_gland | 0.87319257 |
84 | MP0003252_abnormal_bile_duct | 0.87194355 |
85 | MP0002998_abnormal_bone_remodeling | 0.87119229 |
86 | MP0005174_abnormal_tail_pigmentation | 0.87098867 |
87 | MP0003091_abnormal_cell_migration | 0.86650531 |
88 | MP0000343_altered_response_to | 0.85365319 |
89 | MP0002019_abnormal_tumor_incidence | 0.83657639 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.83599474 |
91 | MP0001663_abnormal_digestive_system | 0.83376361 |
92 | MP0000598_abnormal_liver_morphology | 0.81472574 |
93 | MP0005164_abnormal_response_to | 0.79910563 |
94 | MP0010329_abnormal_lipoprotein_level | 0.79505676 |
95 | * MP0005390_skeleton_phenotype | 0.78496723 |
96 | MP0000371_diluted_coat_color | 0.78300070 |
97 | MP0003075_altered_response_to | 0.77089848 |
98 | MP0001958_emphysema | 0.75431671 |
99 | MP0002009_preneoplasia | 0.74732311 |
100 | MP0002136_abnormal_kidney_physiology | 0.74609352 |
101 | MP0003045_fibrosis | 0.73704149 |
102 | MP0005319_abnormal_enzyme/_coenzyme | 0.73456599 |
103 | MP0000249_abnormal_blood_vessel | 0.73043299 |
104 | MP0003279_aneurysm | 0.72879871 |
105 | MP0002877_abnormal_melanocyte_morpholog | 0.71574490 |
106 | MP0003795_abnormal_bone_structure | 0.71249710 |
107 | MP0005166_decreased_susceptibility_to | 0.70095140 |
108 | MP0008057_abnormal_DNA_replication | 0.68539030 |
109 | MP0001851_eye_inflammation | 0.68367406 |
110 | MP0008874_decreased_physiological_sensi | 0.67150121 |
111 | MP0004185_abnormal_adipocyte_glucose | 0.67138786 |
112 | MP0008004_abnormal_stomach_pH | 0.64413146 |
113 | MP0005666_abnormal_adipose_tissue | 0.62868775 |
114 | MP0000015_abnormal_ear_pigmentation | 0.60333857 |
115 | MP0004858_abnormal_nervous_system | 0.59640372 |
116 | MP0009643_abnormal_urine_homeostasis | 0.59575683 |
117 | MP0005085_abnormal_gallbladder_physiolo | 0.59294786 |
118 | MP0001915_intracranial_hemorrhage | 0.59065945 |
119 | MP0005621_abnormal_cell_physiology | 0.58826422 |
120 | MP0005451_abnormal_body_composition | 0.58144390 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.07038800 |
2 | Recurrent abscess formation (HP:0002722) | 4.82354602 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.60421522 |
4 | Chronic otitis media (HP:0000389) | 3.96542606 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.90589002 |
6 | * Recurrent fungal infections (HP:0002841) | 3.77559237 |
7 | Nasal polyposis (HP:0100582) | 3.73019723 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72587065 |
9 | * Recurrent viral infections (HP:0004429) | 3.70661813 |
10 | Colitis (HP:0002583) | 3.63788941 |
11 | Autoimmune thrombocytopenia (HP:0001973) | 3.53368737 |
12 | Pustule (HP:0200039) | 3.52496888 |
13 | Myositis (HP:0100614) | 3.50678183 |
14 | Abnormality of macrophages (HP:0004311) | 3.45187748 |
15 | Recurrent skin infections (HP:0001581) | 3.38986656 |
16 | Abnormality of the nasal mucosa (HP:0000433) | 3.35039065 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.33898907 |
18 | Inflammation of the large intestine (HP:0002037) | 3.24004165 |
19 | Gastrointestinal inflammation (HP:0004386) | 3.16109824 |
20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08268055 |
21 | Myocardial infarction (HP:0001658) | 3.08214075 |
22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05877539 |
23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05877539 |
24 | Recurrent bronchitis (HP:0002837) | 3.02428612 |
25 | Periodontitis (HP:0000704) | 3.01186261 |
26 | Vasculitis (HP:0002633) | 2.99021917 |
27 | Cellulitis (HP:0100658) | 2.95047520 |
28 | Orchitis (HP:0100796) | 2.94381472 |
29 | Systemic lupus erythematosus (HP:0002725) | 2.83534521 |
30 | Gingivitis (HP:0000230) | 2.81670060 |
31 | Increased cerebral lipofuscin (HP:0011813) | 2.81389808 |
32 | Gingival bleeding (HP:0000225) | 2.78494805 |
33 | Hematochezia (HP:0002573) | 2.73128035 |
34 | IgM deficiency (HP:0002850) | 2.73056688 |
35 | Retrobulbar optic neuritis (HP:0100654) | 2.68518963 |
36 | Optic neuritis (HP:0100653) | 2.68518963 |
37 | Arterial thrombosis (HP:0004420) | 2.66246753 |
38 | Abnormality of the fingertips (HP:0001211) | 2.66107530 |
39 | Meningitis (HP:0001287) | 2.64704732 |
40 | Thrombocytosis (HP:0001894) | 2.64180542 |
41 | Abnormality of T cell number (HP:0011839) | 2.61276698 |
42 | Fatigue (HP:0012378) | 2.61230373 |
43 | Spontaneous hematomas (HP:0007420) | 2.60345868 |
44 | T lymphocytopenia (HP:0005403) | 2.59105655 |
45 | Vacuolated lymphocytes (HP:0001922) | 2.56337797 |
46 | Abnormality of T cells (HP:0002843) | 2.54402457 |
47 | Agammaglobulinemia (HP:0004432) | 2.51206287 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.49893366 |
49 | Gastrointestinal infarctions (HP:0005244) | 2.49689443 |
50 | Panhypogammaglobulinemia (HP:0003139) | 2.48091317 |
51 | Abnormality of T cell physiology (HP:0011840) | 2.46848693 |
52 | Stomatitis (HP:0010280) | 2.46515419 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46365718 |
54 | Epistaxis (HP:0000421) | 2.43092679 |
55 | Leukocytosis (HP:0001974) | 2.42491721 |
56 | Pulmonary infiltrates (HP:0002113) | 2.38100974 |
57 | Obstructive lung disease (HP:0006536) | 2.35464600 |
58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35464600 |
59 | Emphysema (HP:0002097) | 2.32273753 |
60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28958239 |
61 | Osteolytic defects of the hand bones (HP:0009699) | 2.28958239 |
62 | Hypochromic anemia (HP:0001931) | 2.27769550 |
63 | Viral hepatitis (HP:0006562) | 2.24578151 |
64 | Osteomyelitis (HP:0002754) | 2.24170933 |
65 | Polycythemia (HP:0001901) | 2.24119181 |
66 | Eosinophilia (HP:0001880) | 2.20844591 |
67 | Hemoptysis (HP:0002105) | 2.20108244 |
68 | Keratoconjunctivitis (HP:0001096) | 2.19372352 |
69 | Broad face (HP:0000283) | 2.16666542 |
70 | Lymphopenia (HP:0001888) | 2.15866556 |
71 | Amyloidosis (HP:0011034) | 2.15442838 |
72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15338068 |
73 | Abnormality of the peritoneum (HP:0002585) | 2.15252654 |
74 | * Increased IgE level (HP:0003212) | 2.14660524 |
75 | Prolonged bleeding time (HP:0003010) | 2.14123080 |
76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12608776 |
77 | Glomerulonephritis (HP:0000099) | 2.11739001 |
78 | Esophageal varix (HP:0002040) | 2.11480215 |
79 | Urticaria (HP:0001025) | 2.10013252 |
80 | Chest pain (HP:0100749) | 2.09448245 |
81 | Impaired platelet aggregation (HP:0003540) | 2.07887445 |
82 | Abnormal platelet function (HP:0011869) | 2.07887445 |
83 | Hemorrhage of the eye (HP:0011885) | 2.07847052 |
84 | Complement deficiency (HP:0004431) | 2.06931512 |
85 | Sepsis (HP:0100806) | 2.04874977 |
86 | Skin ulcer (HP:0200042) | 2.04544571 |
87 | Loss of speech (HP:0002371) | 2.04429972 |
88 | Purpura (HP:0000979) | 2.04332685 |
89 | Abnormal platelet volume (HP:0011876) | 2.04238212 |
90 | Papilloma (HP:0012740) | 2.02806414 |
91 | Verrucae (HP:0200043) | 2.02806414 |
92 | Gastrointestinal stroma tumor (HP:0100723) | 2.02259892 |
93 | Hypertensive crisis (HP:0100735) | 2.01732606 |
94 | Granulocytopenia (HP:0001913) | 2.01291675 |
95 | Episodic fever (HP:0001954) | 2.00089684 |
96 | Increased IgM level (HP:0003496) | 1.99641368 |
97 | IgA deficiency (HP:0002720) | 1.99126047 |
98 | Obstructive sleep apnea (HP:0002870) | 1.98220053 |
99 | Petechiae (HP:0000967) | 1.97182952 |
100 | Malnutrition (HP:0004395) | 1.96882531 |
101 | Slow saccadic eye movements (HP:0000514) | 1.95543037 |
102 | Polygenic inheritance (HP:0010982) | 1.95522474 |
103 | Dysostosis multiplex (HP:0000943) | 1.93578640 |
104 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93390811 |
105 | Premature loss of primary teeth (HP:0006323) | 1.92877161 |
106 | Encephalitis (HP:0002383) | 1.92259738 |
107 | Joint hemorrhage (HP:0005261) | 1.92248964 |
108 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91531805 |
109 | Increased serum ferritin (HP:0003281) | 1.91283944 |
110 | Pulmonary embolism (HP:0002204) | 1.90439147 |
111 | Chronic diarrhea (HP:0002028) | 1.90297042 |
112 | Hepatosplenomegaly (HP:0001433) | 1.90289167 |
113 | Deep venous thrombosis (HP:0002625) | 1.89633680 |
114 | Frequent falls (HP:0002359) | 1.89304748 |
115 | Keratoconjunctivitis sicca (HP:0001097) | 1.88652836 |
116 | Thrombophlebitis (HP:0004418) | 1.88421739 |
117 | Abnormality of the pleura (HP:0002103) | 1.86401333 |
118 | Abnormality of complement system (HP:0005339) | 1.85360363 |
119 | Restrictive lung disease (HP:0002091) | 1.84385476 |
120 | Peritonitis (HP:0002586) | 1.83836833 |
121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83671313 |
122 | Mucopolysacchariduria (HP:0008155) | 1.83671313 |
123 | Recurrent sinusitis (HP:0011108) | 1.83058228 |
124 | Cerebral aneurysm (HP:0004944) | 1.82756324 |
125 | Metaphyseal cupping (HP:0003021) | 1.82524420 |
126 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80889429 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.13573317 |
2 | PRPF4B | 3.57326575 |
3 | * TYK2 | 3.08708733 |
4 | MAP3K14 | 3.08213939 |
5 | JAK3 | 2.72170614 |
6 | ERN1 | 2.65930234 |
7 | TBK1 | 2.58936876 |
8 | BLK | 2.42020719 |
9 | IKBKE | 2.31992319 |
10 | MAP3K10 | 2.24067696 |
11 | SMG1 | 2.23670041 |
12 | FGFR4 | 2.22272225 |
13 | MAP3K13 | 2.22130856 |
14 | TRIB3 | 2.13274723 |
15 | STK10 | 2.05743775 |
16 | * JAK1 | 2.03874785 |
17 | EPHB1 | 1.98383543 |
18 | IRAK3 | 1.96084624 |
19 | PKN2 | 1.94263938 |
20 | IKBKB | 1.94114418 |
21 | IRAK4 | 1.92486637 |
22 | KIT | 1.88446295 |
23 | TNK2 | 1.86793159 |
24 | EEF2K | 1.86672097 |
25 | ZAP70 | 1.85159987 |
26 | TAOK3 | 1.80790428 |
27 | TXK | 1.65609890 |
28 | CDK12 | 1.63405891 |
29 | CSF1R | 1.63011200 |
30 | RIPK4 | 1.61870276 |
31 | GRK6 | 1.52228986 |
32 | CSK | 1.48729544 |
33 | CHUK | 1.42943964 |
34 | FLT3 | 1.41371596 |
35 | LRRK2 | 1.37325052 |
36 | RPS6KA4 | 1.33869118 |
37 | PTK6 | 1.31176397 |
38 | TTN | 1.30535778 |
39 | BTK | 1.30026545 |
40 | SIK3 | 1.28976960 |
41 | SYK | 1.27966120 |
42 | FGFR3 | 1.25850121 |
43 | HCK | 1.23652570 |
44 | JAK2 | 1.23472181 |
45 | MARK2 | 1.23182411 |
46 | TGFBR2 | 1.18369176 |
47 | PIM1 | 1.18176349 |
48 | LCK | 1.17927292 |
49 | MAP3K1 | 1.15413195 |
50 | ICK | 1.15228845 |
51 | SIK1 | 1.14521353 |
52 | PRKD2 | 1.14206039 |
53 | CDC42BPA | 1.13210619 |
54 | ITK | 1.13206892 |
55 | SIK2 | 1.09685309 |
56 | KSR2 | 1.06514685 |
57 | MAP2K3 | 1.06293488 |
58 | TAOK2 | 1.03659476 |
59 | NEK2 | 1.02535180 |
60 | MARK3 | 0.95196368 |
61 | CDK4 | 0.90167167 |
62 | MAP3K6 | 0.88301597 |
63 | EPHA3 | 0.86945614 |
64 | CAMK1D | 0.85792234 |
65 | MAPK12 | 0.85765886 |
66 | RIPK1 | 0.82076865 |
67 | MAPK7 | 0.77572216 |
68 | LYN | 0.77049161 |
69 | STK4 | 0.76250196 |
70 | CDK6 | 0.74746737 |
71 | TEC | 0.71353917 |
72 | BMX | 0.70648462 |
73 | MAP3K8 | 0.68309813 |
74 | IRAK2 | 0.66469258 |
75 | MAPK11 | 0.65768015 |
76 | CAMKK1 | 0.65175015 |
77 | FES | 0.64276874 |
78 | NEK9 | 0.63745375 |
79 | NLK | 0.62946640 |
80 | PAK4 | 0.58702819 |
81 | RPS6KA2 | 0.56816638 |
82 | SCYL2 | 0.56553268 |
83 | ALK | 0.55229481 |
84 | KDR | 0.54489028 |
85 | RET | 0.53017163 |
86 | BMPR2 | 0.51886309 |
87 | PRKAA2 | 0.49882656 |
88 | STK3 | 0.48912195 |
89 | MTOR | 0.47825904 |
90 | TESK2 | 0.47344513 |
91 | PDK1 | 0.46780747 |
92 | PIM2 | 0.46443094 |
93 | PRKCQ | 0.46216675 |
94 | TRPM7 | 0.45690839 |
95 | YES1 | 0.45661501 |
96 | EGFR | 0.45333727 |
97 | RPS6KA6 | 0.45001880 |
98 | MAP2K2 | 0.44657690 |
99 | MAP3K7 | 0.43243746 |
100 | MAPKAPK2 | 0.43156661 |
101 | MAP3K11 | 0.42816893 |
102 | DYRK1B | 0.42669154 |
103 | NME2 | 0.42462951 |
104 | ABL1 | 0.42099296 |
105 | MATK | 0.41531281 |
106 | CAMK1G | 0.40583130 |
107 | * FYN | 0.39704703 |
108 | CLK1 | 0.39265777 |
109 | PASK | 0.37230777 |
110 | IRAK1 | 0.37222999 |
111 | MAP2K6 | 0.36881702 |
112 | PDGFRB | 0.36870243 |
113 | MAP3K3 | 0.36511831 |
114 | FGR | 0.36327420 |
115 | MAPK4 | 0.35902246 |
116 | SGK3 | 0.35226335 |
117 | MELK | 0.35074630 |
118 | RPS6KA1 | 0.33746167 |
119 | RPS6KB2 | 0.33385471 |
120 | RPS6KC1 | 0.32558231 |
121 | RPS6KL1 | 0.32558231 |
122 | TAOK1 | 0.32091248 |
123 | HIPK2 | 0.30386631 |
124 | MAPKAPK3 | 0.28785133 |
125 | PDPK1 | 0.28327472 |
126 | CDK9 | 0.27275788 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78626698 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.72919991 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.72516295 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48430185 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35016835 |
6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29121645 |
7 | * Measles_Homo sapiens_hsa05162 | 2.23707407 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17273811 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10122664 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00278932 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94908856 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89553925 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83523699 |
14 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.68871919 |
15 | * Influenza A_Homo sapiens_hsa05164 | 1.67758757 |
16 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.66118002 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64442826 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.59520229 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59155839 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58981953 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 1.57717919 |
22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56753164 |
23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56185143 |
24 | Apoptosis_Homo sapiens_hsa04210 | 1.55004233 |
25 | Tuberculosis_Homo sapiens_hsa05152 | 1.54686964 |
26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54469286 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53833005 |
28 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50069149 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44839757 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.40567931 |
31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39783247 |
32 | Malaria_Homo sapiens_hsa05144 | 1.27179748 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24928334 |
34 | Shigellosis_Homo sapiens_hsa05131 | 1.24396824 |
35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21136660 |
36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20347296 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.20064521 |
38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19183262 |
39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17881901 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15016568 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.14680201 |
42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12889889 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11863146 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09829770 |
45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09759157 |
46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01125289 |
47 | * Hepatitis C_Homo sapiens_hsa05160 | 1.00576479 |
48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99440645 |
49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96788985 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96509330 |
51 | ABC transporters_Homo sapiens_hsa02010 | 0.95996776 |
52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95449100 |
53 | Insulin resistance_Homo sapiens_hsa04931 | 0.91555116 |
54 | Asthma_Homo sapiens_hsa05310 | 0.88213215 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86039265 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85985338 |
57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84054631 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83756265 |
59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83349328 |
60 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82995859 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.82065152 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82057113 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79701121 |
64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79063560 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78807370 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78734730 |
67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77291342 |
68 | Salmonella infection_Homo sapiens_hsa05132 | 0.77098340 |
69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76638852 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75317283 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74986993 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.74524008 |
73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70070597 |
74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69973876 |
75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69361691 |
76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68962032 |
77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68144748 |
78 | Bladder cancer_Homo sapiens_hsa05219 | 0.66767863 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64620607 |
80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63624337 |
81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63242410 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63201148 |
83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62573762 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62478348 |
85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61628144 |
86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61397058 |
87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60832343 |
88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60382785 |
89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57830935 |
90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57713591 |
91 | Glioma_Homo sapiens_hsa05214 | 0.57651371 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57505589 |
93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56722613 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55176605 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.54838971 |
96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54359835 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53980359 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52174016 |
99 | Amoebiasis_Homo sapiens_hsa05146 | 0.51900994 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50242799 |
101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50208486 |
102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50205189 |
103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50077119 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49391599 |
105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49222474 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48843294 |
107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47850565 |
108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46714665 |
109 | Prion diseases_Homo sapiens_hsa05020 | 0.46554680 |
110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45156464 |
111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44629048 |
112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41448035 |
113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38357871 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35716390 |
115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33828031 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33407442 |
117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31031707 |
118 | Phagosome_Homo sapiens_hsa04145 | 0.30104621 |
119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29896835 |
120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29030288 |
121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27582379 |
122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25146505 |
123 | Base excision repair_Homo sapiens_hsa03410 | 0.24432138 |
124 | Endocytosis_Homo sapiens_hsa04144 | 0.23923226 |